Total Payments
$856.23
2024 Payments
$20.87
Companies
10
Transactions
28
Medicare Patients
3,298
Medicare Billing
$435,644
Payment Breakdown by Category
Food & Beverage$856.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $856.23 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $293.83 | 6 | $0 (2020) |
| Abbott Laboratories | $180.90 | 2 | $0 (2021) |
| Amgen Inc. | $154.43 | 10 | $0 (2020) |
| Relievant Medsystems, Inc. | $62.88 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $51.78 | 3 | $0 (2018) |
| Amneal Pharmaceuticals LLC | $28.99 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $26.03 | 1 | $0 (2019) |
| Curonix LLC | $20.87 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $19.85 | 1 | $0 (2023) |
| Vertical Pharmaceuticals, LLC | $16.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.87 | 1 | Curonix LLC ($20.87) |
| 2023 | $111.72 | 4 | Relievant Medsystems, Inc. ($62.88) |
| 2021 | $30.35 | 1 | Abbott Laboratories ($30.35) |
| 2020 | $309.66 | 10 | Abbott Laboratories ($150.55) |
| 2019 | $101.25 | 6 | Amgen Inc. ($75.22) |
| 2018 | $157.64 | 4 | AbbVie, Inc. ($105.86) |
| 2017 | $124.74 | 2 | AbbVie, Inc. ($108.07) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/04/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Opioid Analgesic | ||||||
| 08/15/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROLOGY | ||||||
| 06/15/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROLOGY | ||||||
| 01/30/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $62.88 | General |
| Category: Pain | ||||||
| 08/31/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Heart Failure | ||||||
| 11/18/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Inflammation | ||||||
| 10/28/2020 | AbbVie Inc. | RINVOQ (Drug), HUMIRA | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2020 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Inflammation | ||||||
| 10/21/2020 | AbbVie Inc. | RINVOQ (Drug), HUMIRA | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2020 | AbbVie Inc. | RINVOQ (Drug), HUMIRA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/02/2020 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation | ||||||
| 08/26/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Bone Health | ||||||
| 03/18/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $150.55 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/27/2020 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Inflammation | ||||||
| 12/05/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Inflammation | ||||||
| 08/08/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Inflammation | ||||||
| 06/26/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Inflammation | ||||||
| 04/11/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Inflammation | ||||||
| 02/28/2019 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Inflammation | ||||||
| 01/04/2019 | Regeneron Healthcare Solutions, Inc. | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 569 | 1,256 | $245,691 | $81,836 |
| 2022 | 11 | 597 | 1,355 | $236,639 | $79,723 |
| 2021 | 13 | 754 | 1,493 | $271,632 | $95,933 |
| 2020 | 16 | 1,378 | 3,234 | $528,558 | $178,152 |
Total Patients
3,298
Total Services
7,338
Medicare Billing
$435,644
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 585 | $137,475 | $47,022 | 34.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 109 | 186 | $36,456 | $13,227 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 84 | $13,272 | $4,999 | 37.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 49 | 50 | $15,950 | $4,828 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $14,079 | $4,450 | 31.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 24 | 24 | $10,152 | $3,135 | 30.9% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 31 | 31 | $8,339 | $2,340 | 28.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 18 | $6,360 | $911.55 | 14.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 15 | 19 | $2,508 | $750.91 | 29.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 220 | $1,100 | $172.30 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 519 | $121,965 | $43,231 | 35.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 101 | 174 | $34,104 | $13,133 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 107 | $16,906 | $6,064 | 35.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 46 | 46 | $14,674 | $4,648 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $13,718 | $4,422 | 32.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 20 | 20 | $8,460 | $2,346 | 27.7% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 28 | 28 | $7,532 | $2,236 | 29.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 21 | 36 | $13,250 | $2,003 | 15.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 20 | 26 | $3,432 | $1,074 | 31.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 39 | 348 | $1,740 | $299.83 | 17.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 12 | 13 | $858.00 | $266.48 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 501 | $117,735 | $43,759 | 37.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 115 | 214 | $41,944 | $16,799 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 165 | $26,070 | $9,599 | 36.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 80 | 80 | $28,880 | $9,525 | 33.0% |
About Dr. Nancy Mcdonough, M.D
Dr. Nancy Mcdonough, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396857983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Mcdonough, M.D has received a total of $856.23 in payments from pharmaceutical and medical device companies, with $20.87 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($856.23).
As a Medicare-enrolled provider, Mcdonough has provided services to 3,298 Medicare beneficiaries, totaling 7,338 services with total Medicare billing of $435,644. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Cincinnati, OH
- Active Since 08/31/2006
- Last Updated 09/08/2015
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1396857983
Products in Payments
- Proclaim Family of SCS IPGs (Device) $150.55
- Enbrel (Biological) $112.43
- Intracept (Device) $62.88
- RINVOQ (Drug) $54.46
- AIMOVIG (Biological) $31.69
- CardioMEMS HF System (Device) $30.35
- LYVISPAH (Drug) $28.99
- KEVZARA (Biological) $26.03
- HUMIRA (Biological) $25.44
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $20.87
- Belbuca (Drug) $19.85
- Otezla (Drug) $17.47
- DIVIGEL (Drug) $16.67
- AVSOLA (Biological) $12.43
- EVENITY (Biological) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Cincinnati
Dr. Marc Orlando, Md, MD
Physical Medicine & Rehabilitation — Payments: $172,693
Physical Medicine & Rehabilitation $172,693
Sara Nashi, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $87,877
Physical Medicine & Rehabilitation $87,877
Aarti Singla, Md, MD
Physical Medicine & Rehabilitation — Payments: $24,942
Physical Medicine & Rehabilitation $24,942
Ian Kowalski, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,507
Physical Medicine & Rehabilitation $3,507
Dr. Travis Mcclain, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,084
Physical Medicine & Rehabilitation $3,084
Dr. Donald Carruthers, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,745
Physical Medicine & Rehabilitation $2,745